Gauss

LEGEND MAX Human Granzyme B ELISA Kit 1 Pre-coated Plate

Réf. UGAP : 3689283 Réf. Fournisseur : 439207 Réf. Constructeur : 439207
LEGEND MAX Human Granzyme B ELISA Kit 1 Pre-coated Plate
LEGEND MAX Human Granzyme B ELISA Kit 1 Pre-coated Plate
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Granzymes are serine proteases that are released by cytoplasmic granules within cytotoxic T cells and natural killer cells. Human Granzyme B is one of the five members of the human granzyme family which includes Granzymes A, B, G, H, and K. Granzyme B is also known as Granzyme 2, serine protease B (CSP-B for cytotoxic serine protease B), and CCP1 (cytotoxic cell protease-1). It is expressed as a 32 kD protein encoded by the GZMB gene. While Granzyme B is mostly expressed by CTL (Cytotoxic T Lymphocyte) and NK cells, it is also expressed in resting and activated plasmacytoid dendritic cells. Much lower levels are found in monocytes, resting T-cells, B-cells, activated granulocytes, and activated monocyte-derived dendritic cells. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTL in the cell-mediated immune response. Granzyme B and perforin have been shown to induce CTL-mediated target cell DNA fragmentation and apoptosis. Once released from the CTL, Granzyme B binds its receptor, the mannose-6-phosphate/ insulin-like growth factor II receptor, and is endocytosed but remains arrested in endeocytic vesicles until released by perforin. Once in the cytosol, Granzyme B targets caspase-3 and other caspases directly or indirectly through the mitochondria, initiating the caspase cascade which leads to DNA fragmentation and apoptosis. Elevated Granzyme B levels have been linked with various disease processes. For example, increased levels of soluble granzymes have been found in patients with systemic viral infections. It has also been shown that the presence of a high percentage of Granzyme B positive CTLs in the glands of patients suffering from Hodgkin's disease correlates with a severe prognosis. Synovial fluid from rheumatoid arthritis patients has elevated soluble Granzyme A and B levels compared with healthy donors and patients with osteoarthrosis. BioLegend's LEGEND MAX™ Human Granzyme B ELISA Kit is a sandwich Enzyme-Linked Immunosorbent Assay (ELISA), in which, a human Granzyme B -specific monoclonal antibody is pre-coated on a 96-well strip-well plate. BioLegend's LEGEND MAX™ Human Granzyme B ELISA Kit is specifically designed for the accurate quantitation of Human Granzyme B from cell culture supernatant, serum, plasma, or other bodily fluids. It is ready-to-use, accurate, and sensitive.;

En savoir plus

Garantie

Garantie 0 Mois

Description

Granzymes are serine proteases that are released by cytoplasmic granules within cytotoxic T cells and natural killer cells. Human Granzyme B is one of the five members of the human granzyme family which includes Granzymes A, B, G, H, and K. Granzyme B is also known as Granzyme 2, serine protease B (CSP-B for cytotoxic serine protease B), and CCP1 (cytotoxic cell protease-1). It is expressed as a 32 kD protein encoded by the GZMB gene. While Granzyme B is mostly expressed by CTL (Cytotoxic T Lymphocyte) and NK cells, it is also expressed in resting and activated plasmacytoid dendritic cells. Much lower levels are found in monocytes, resting T-cells, B-cells, activated granulocytes, and activated monocyte-derived dendritic cells. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTL in the cell-mediated immune response. Granzyme B and perforin have been shown to induce CTL-mediated target cell DNA fragmentation and apoptosis. Once released from the CTL, Granzyme B binds its receptor, the mannose-6-phosphate/ insulin-like growth factor II receptor, and is endocytosed but remains arrested in endeocytic vesicles until released by perforin. Once in the cytosol, Granzyme B targets caspase-3 and other caspases directly or indirectly through the mitochondria, initiating the caspase cascade which leads to DNA fragmentation and apoptosis. Elevated Granzyme B levels have been linked with various disease processes. For example, increased levels of soluble granzymes have been found in patients with systemic viral infections. It has also been shown that the presence of a high percentage of Granzyme B positive CTLs in the glands of patients suffering from Hodgkin's disease correlates with a severe prognosis. Synovial fluid from rheumatoid arthritis patients has elevated soluble Granzyme A and B levels compared with healthy donors and patients with osteoarthrosis. BioLegend's LEGEND MAX™ Human Granzyme B ELISA Kit is a sandwich Enzyme-Linked Immunosorbent Assay (ELISA), in which, a human Granzyme B -specific monoclonal antibody is pre-coated on a 96-well strip-well plate. BioLegend's LEGEND MAX™ Human Granzyme B ELISA Kit is specifically designed for the accurate quantitation of Human Granzyme B from cell culture supernatant, serum, plasma, or other bodily fluids. It is ready-to-use, accurate, and sensitive.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
439207
Référence distributeur
439207
Vendu par
1 pre-coated plate
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
ELISA Kit
Certification
RUO
Type d’application
ELISA
Type de produit
kit
Température de conservation (°C)
entre 2 et 8 °C
Température de transport
ambiante
Méthode de détection
colorimétrique
Méthode de dosage
ELISA
Organisme cible
Human
Matière dangereuse
non
Code douanier
38220000
Classement NCBI
3002
Nomenclature Nacres
NA.84
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA84
Nomenclature CNRS
NA84
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Reprise en cas d’erreur client
non